The clinical course of SARS-CoV-2 infection in patients with glomerular diseases and evaluation of the subsequent risk of relapse
SARS-CoV-2 infection appears to have a symptomatic but uncomplicated sequence in vaccinated patients with GDs, with a significant impact on the clinical course of GD, associated with an increased probability of relapse in certain histopathological types.
Authors
- Sophia Lionaki (ORCID: https://orcid.org/0000-0003-1643-8923)
- Vassilios Liakopoulos (ORCID: https://orcid.org/0000-0002-7564-2724)
- Aggeliki Sardeli
- Stylianos Panagoutsos
- Aliki I. Venetsanopoulou (ORCID: https://orcid.org/0000-0003-4280-9193)
- Evangelia C. Dounousi (ORCID: https://orcid.org/0000-0002-1172-1829)
- Petros Kalogeropoulos (ORCID: https://orcid.org/0000-0002-7708-5431)
- Ioannis Boletis (ORCID: https://orcid.org/0000-0003-4664-8921)
- Ioannis Bellos (ORCID: https://orcid.org/0000-0001-5088-5458)
- Smaragdi Marinaki (ORCID: https://orcid.org/0000-0002-5920-3086)
- Konstantia Kantartzi (ORCID: https://orcid.org/0000-0002-9366-7466)
- Dimitra Galitsiou
- Eva Andronikidi
- Marios Papasotiriou (ORCID: https://orcid.org/0000-0001-9375-989X)
- Georgios Moustakas
- Christos Mpintas
- Sophia Flouda
- Paraskevi Voulgari
- Dimitrios Goumenos
Institutions
- Democritus University of Thrace (GR)
- National and Kapodistrian University of Athens (GR)
- AHEPA University Hospital (GR)
- General University Hospital of Patras (GR)
- General Hospital of Athens G. Genimatas (GR)
- Laiko General Hospital of Athens (GR)
- Aretaeio Hospital (GR)
- University Hospital of Ioannina (GR)
Publication Details
- Journal
- Frontiers in Nephrology
- Published
- 2024-10-21
- DOI
- https://doi.org/10.3389/fneph.2024.1472294
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00